Diabetes Metab J.  2020 Jun;44(3):402-404. 10.4093/dmj.2020.0126.

Smoking as a Target for Prevention of Diabetes

Affiliations
  • 0Department of Internal Medicine, Uijeongbu St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.


Cited by  1 articles

Association between Smoking Status and the Risk of Hip Fracture in Patients with Type 2 Diabetes: A Nationwide Population-Based Study
Se-Won Lee, Jun-Young Heu, Ju-Yeong Kim, Jinyoung Kim, Kyungdo Han, Hyuk-Sang Kwon
Endocrinol Metab. 2023;38(6):679-689.    doi: 10.3803/EnM.2023.1760.


Reference

1. Kwak SH, Park KS. Pathophysiology of type 2 diabetes in Koreans. Endocrinol Metab (Seoul). 2018; 33:9–16. PMID: 29589384.
Article
2. Kim BY, Won JC, Lee JH, Kim HS, Park JH, Ha KH, Won KC, Kim DJ, Park KS. Diabetes fact sheets in Korea, 2018: an appraisal of current status. Diabetes Metab J. 2019; 43:487–494. PMID: 31339012.
Article
3. Baik I. Projection of diabetes prevalence in Korean adults for the year 2030 using risk factors identified from national data. Diabetes Metab J. 2019; 43:90–96. PMID: 30398038.
Article
4. Korean Diabetes Association. Diabetes & Complications in Korea [Internet]. updated 2019 Oct 10. Available from: https://www.diabetes.or.kr/pro/news/admin.php?category=A&code=admin&number=1788&mode=view.
5. Li G, Zhang P, Wang J, An Y, Gong Q, Gregg EW, Yang W, Zhang B, Shuai Y, Hong J, Engelgau MM, Li H, Roglic G, Hu Y, Bennett PH. Cardiovascular mortality, all-cause mortality, and diabetes incidence after lifestyle intervention for people with impaired glucose tolerance in the Da Qing Diabetes Prevention Study: a 23-year follow-up study. Lancet Diabetes Endocrinol. 2014; 2:474–480. PMID: 24731674.
Article
6. Diabetes Prevention Program Research Group. Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the Diabetes Prevention Program Outcomes Study. Lancet Diabetes Endocrinol. 2015; 3:866–875. PMID: 26377054.
7. Lee YH, Bang H, Kim HC, Kim HM, Park SW, Kim DJ. A simple screening score for diabetes for the Korean population: development, validation, and comparison with other scores. Diabetes Care. 2012; 35:1723–1730. PMID: 22688547.
Article
8. Ha KH, Lee YH, Song SO, Lee JW, Kim DW, Cho KH, Kim DJ. Development and validation of the Korean diabetes risk score: a 10-year national cohort study. Diabetes Metab J. 2018; 42:402–414. PMID: 30113144.
Article
9. American Diabetes Association. 3. Prevention or delay of type 2 diabetes: standards of medical care in diabetes. 2020. Diabetes Care. 2020; 43(Suppl 1):S32–S36. PMID: 31862746.
10. Kim JH, Seo DC, Kim BJ, Kang JG, Lee SJ, Lee SH, Kim BS, Kang JH. Association between cigarette smoking and new-onset diabetes mellitus in 78,212 Koreans using self-reported questionnaire and urine cotinine. Diabetes Metab J. 2020; 44:426–438.
Article
11. Hur NW, Kim HC, Nam CM, Jee SH, Lee HC, Suh I. Smoking cessation and risk of type 2 diabetes mellitus: Korea Medical Insurance Corporation Study. Eur J Cardiovasc Prev Rehabil. 2007; 14:244–249. PMID: 17446803.
Article
12. Jee SH, Foong AW, Hur NW, Samet JM. Smoking and risk for diabetes incidence and mortality in Korean men and women. Diabetes Care. 2010; 33:2567–2572. PMID: 20823342.
Article
13. Pan A, Wang Y, Talaei M, Hu FB, Wu T. Relation of active, passive, and quitting smoking with incident type 2 diabetes: a systematic review and meta-analysis. Lancet Diabetes Endocrinol. 2015; 3:958–967. PMID: 26388413.
Article
14. Akter S, Goto A, Mizoue T. Smoking and the risk of type 2 diabetes in Japan: a systematic review and meta-analysis. J Epidemiol. 2017; 27:553–561. PMID: 28716381.
Article
15. Hu Y, Zong G, Liu G, Wang M, Rosner B, Pan A, Willett WC, Manson JE, Hu FB, Sun Q. Smoking cessation, weight change, type 2 diabetes, and mortality. N Engl J Med. 2018; 379:623–632. PMID: 30110591.
Article
16. Farley AC, Hajek P, Lycett D, Aveyard P. Interventions for preventing weight gain after smoking cessation. Cochrane Database Syst Rev. 2012; 1:CD006219. PMID: 22258966.
Article
17. Acosta M, Buchhalter A, Breland A, Hamilton D, Eissenberg T. Urine cotinine as an index of smoking status in smokers during 96-hr abstinence: comparison between gas chromatography/mass spectrometry and immunoassay test strips. Nicotine Tob Res. 2004; 6:615–620. PMID: 15370157.
Article
18. Schepis TS, Duhig AM, Liss T, McFetridge A, Wu R, Cavallo DA, Dahl T, Jatlow P, Krishnan-Sarin S. Contingency management for smoking cessation: enhancing feasibility through use of immunoassay test strips measuring cotinine. Nicotine Tob Res. 2008; 10:1495–1501. PMID: 19023841.
Article
19. Benowitz NL, Bernert JT, Foulds J, Hecht SS, Jacob P, Jarvis MJ, Joseph A, Oncken C, Piper ME. Biochemical verification of tobacco use and abstinence: 2019 update. Nicotine Tob Res. 2020; 22:1086–1097. PMID: 31570931.
Article
20. Cha SA, Lim SY, Kim KR, Lee EY, Kang B, Choi YH, Yoon KH, Ahn YB, Lee JH, Ko SH. Community-based randomized controlled trial of diabetes prevention study for high-risk individuals of type 2 diabetes: lifestyle intervention using web-based system. BMC Public Health. 2017; 17:387. PMID: 28476101.
Article
Full Text Links
  • DMJ
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr